INDIA'S MENTAL HEALTH QUEST
Healthcare Radius
|November 2023
Examine the changing facets of mental health in India. Dive deep intoythe prevalence” of mental disorders, treatment options, government and industry initiatives,,and more.
-
Navigating the mental health landscape in India is like decoding the Indus script. It's complex and enigmatic, yet holds the potential to transform our understanding of the subject. Mental health disorders are a significant concern in India, with a wide range of conditions such as depression, anxiety, substance misuse, psychosis, and dementia affecting the population.
The enormity of the challenge becomes evident when we consider that about 7.5 percent of the Indian population suffers from some form of mental disorder, as observed by the World Health Organization. Mental illnesses constitute one-sixth of all health-related disorders and India accounts for nearly 15 percent of the global mental, neurological, and substance abuse disorder burden. The WHO also estimates that 5.6 crore Indians suffer from depression and another 3.8 crore Indians suffer from anxiety disorders.
In 2017, 19.73 crore people had mental disorders in India, including 4.5 crore with depression and 4.4 crore with anxiety disorders. The WHO estimates that India bears a mental health burden of 2,443 disability-adjusted life years (DALYS) per one-lakh population. The age-adjusted suicide rate is 21.1 per lakh, and the economic loss due to mental health conditions between 2012 and 2030 is estimated at $1.03 trillion (Rs 8,574.76 crore, approximately).
According to India's National Mental Health Survey, 13.7 percent of individuals had experienced some form of mental morbidity at some point in their lifetime. Research found that 10.6 percent of participants were currently affected by mental morbidity. The prevalence rates of mental health disorders in India need intervention and support systems to address the mental well-being of Indian citizens.
This story is from the November 2023 edition of Healthcare Radius.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Healthcare Radius
Healthcare Radius
VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM
Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.
1 mins
December 2025
Healthcare Radius
A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026
The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.
12 mins
December 2025
Healthcare Radius
FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA
From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.
6 mins
December 2025
Healthcare Radius
ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US
Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.
1 min
December 2025
Healthcare Radius
ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).
1 min
December 2025
Healthcare Radius
SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS
Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.
1 min
December 2025
Healthcare Radius
KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL
Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.
1 min
December 2025
Healthcare Radius
INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH
Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.
1 min
December 2025
Healthcare Radius
OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS
By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”
7 mins
December 2025
Healthcare Radius
MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM
Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.
1 min
December 2025
Translate
Change font size

